Biomarkers for preterm births using non-invasive samples

Brief description of study

The purpose of this study is to evaluate if biomarkers measured in body fluids (such as saliva, urine, vaginal fluid, and blood) in pregnant women presenting with symptoms of preterm labor (such as uterine contractions) will predict progression to actual preterm delivery (birth of the baby). Biomarkers are a measurable substance in body fluid that can predict that occurrence of a specific outcome, in this case, it will be preterm birth. The study will compare inflammatory biomarkers from non-invasive samples (blood, urine and saliva) in pregnant women presenting with preterm labor with rapid progression to delivery (3 days or less) compared to pregnant women presenting with preterm labor who deliver more than 3 days from preterm labor.


Clinical Study Identifier: s19-01327
Principal Investigator: Nazeeh N Hanna.


If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.